SCHEMBL31345985

SCHEMBL31345985

FC(F)(F)c1cc(Cl)c2c(c1)C[C@@H](c1cccc(Br)c1)O2

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TEAD1 P28347 2/20 0.37
HTR1A P08908 2/20 0.36
KDM1A O60341 2/20 0.33
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
HTR2B P41595 5/20 0.32
HTR2A P28223 4/20 0.32
HTR2C P28335 4/20 0.32
HRH3 Q9Y5N1 4/20 0.32
FFAR1 O14842 3/20 0.32
MRGPRX4 Q96LA9 1/20 0.31
THRB P10828 1/20 0.31
CHRM2 P08172 1/20 0.31
DRD3 P35462 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31346055 0.83 EZH2 (0.39) KDM1AHTR2BHTR2AHTR2CHRH3
SCHEMBL31346162 0.82 CYP19A1 (0.45) TEAD1HTR1ACYP3A4MRGPRX4DRD3
SCHEMBL31346110 0.82 CYP19A1 (0.45) TEAD1HTR1ACYP3A4MRGPRX4DRD3
SCHEMBL31345956 0.81 LMNA (0.34) TEAD1HTR1AKMT2AMRGPRX4THRB
SCHEMBL31346090 0.81 ALDH1A1 (0.43) FFAR1MRGPRX4THRB
SCHEMBL31346119 0.81 MRGPRX4 (0.42) KMT2AMRGPRX4THRB
SCHEMBL31345967 0.81 CA2 (0.37)
SCHEMBL31346145 0.79 TEAD1 (0.33) TEAD1KDM1ATHRB
SCHEMBL31345963 0.79 TEAD1 (0.42) TEAD1HTR1AKDM1AHTR2BHTR2C
SCHEMBL31346002 0.79 TEAD1 (0.42) TEAD1HTR1AKDM1AHTR2BHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4712967-A2 G-PROTEIN COUPLED RECEPTOR ANTAGONIST Enveda Therapeutics, Inc. (US) 2026-03-25 EP disclosed
WO-2024239000-A2 G-PROTEIN COUPLED RECEPTOR ANTAGONIST ENVEDA THERAPEUTICS, INC. (US) 2024-11-21 WO disclosed